Translational Mitochondrial Medicine (Advances in Biochemistry in Health and Disease Book 32)

★★★★★ 4.2 140 reviews

US$85.88
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by flustix.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$85.88
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 18
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by flustix.com
Free 30-day returns Details

Product details

Management number 231986102 Release Date 2026/06/18 List Price US$85.88 Model Number 231986102
Category

Translational mitochondrial medicine applies the knowledge of experimental medicine in clinical practice, it is a prospective direction of the development of mitochondrial medicine. The monograph "Translational Mitochondrial Medicine" was created on the basis of rapidly developing new information about mitochondrial diseases and their disorders, is a revised and supplemented edition of the monographs: "Mitochondrial Medicine", ed. A. Gvozdjáková, Springer, 2008 and "Recent Advances in Mitochondrial Medicine and Coenzyme Q10", eds. A. Gvozdjáková, G. Cornélissen, RB Singh, NOVA Science, USA, 2018. The monograph was created as part of the book series "Advances in biochemistry in health and disease", edited by prof. Naranjan Dhalla of Winnipeg, for which we are grateful.The book"Translational Mitochondrial Medicine" contributes to the elucidation of the pathobiochemical mechanisms of various diseases, provides current information on the prospective application of the latest diagnostic approaches and targeted therapy of mitochondrial diseases.Perspective mtDNA diagnostic methods include new technologies based on NGS (Next Generation Sequencing) to identify new genes associated with mitochondrial diseases. With the help of the high resolution respirometry method (HRR), it is possible to record even the most subtle deviations of the bioenergetics of mitochondria in blood cells, it contributes to the monitoring of the used daily doses of drugs in patients with various diseases. Determination of the endogenous level of coenzyme Q10 (CoQ10) in platelets is a key method to improve the diagnosis and targeted therapy of damaged mitochondrial bioenergetics. Perspective therapeutic strategies for damaged mitochondria include mitochondrial transplantation, plasma therapy, mitochondrial nanotherapy, weight reduction in obesity, spa rehabilitation, the influence of molecular hydrogen and oxygen therapy. Targeted therapeutic methods for dysfunctional mitochondria and CoQ10 deficiency include supplementation with CoQ10, antioxidants and vitamins.This volume is intended for researchers and physicians looking for new prospective diagnostic approaches and targeted therapies for dysfunctional mitochondria in their patients. Read more

ASIN B0DMQNR4VB
XRay Not Enabled
ISBN13 978-3031757419
Language English
File size 28.4 MB
Page Flip Enabled
Publisher Springer
Word Wise Not Enabled
Print length 783 pages
Accessibility Learn more
Screen Reader Supported
Publication date December 18, 2024
Enhanced typesetting Enabled

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.2 out of 5
★★★★★
140 ratings | 57 reviews
How item rating is calculated
View all reviews
5 stars
78% (109)
4 stars
6% (8)
3 stars
3% (4)
2 stars
2% (3)
1 star
11% (15)
Sort by

There are currently no written reviews for this product.